Showing results (391-400 of 414) with videos related to

Sort By:
Pageof 42
Nature Microbiology|March 17, 2026
Empiric azithromycin alters the upper respiratory microbiome and resistome without anti-inflammatory benefit in COVID-19Abigail Glascock, Cole Maguire, Hoang Van Phan, et al.
Critical Care (London, England)|October 15, 2025
Circulating endothelial signatures correlate with worse outcomes in COVID-19, respiratory failure and ARDSAna C Costa Monteiro, Harry Pickering, Aartik Sarma, et al.
The Journal of Infectious Diseases|April 6, 2022
mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant RecipientsJennie H Kwon, Mark W Tenforde, Manjusha Gaglani, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society|October 6, 2020
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020)Chunxue Bai, Sanjay H Chotirmall, Jordi Rello, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
MMWR. Morbidity and Mortality Weekly Report|August 26, 2021
Sustained Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Associated Hospitalizations Among Adults - United States, March-July 2021Mark W Tenforde, Wesley H Self, Eric A Naioti, et al.
MMWR. Morbidity and Mortality Weekly Report|January 27, 2022
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021Mark W Tenforde, Manish M Patel, Manjusha Gaglani, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
Vaccine Effectiveness of Primary Series and Booster Doses against Omicron Variant COVID-19-Associated Hospitalization in the United StatesKatherine Adams, Jillian P Rhoads, Diya Surie, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 6, 2024
Effectiveness of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity-IVY Network, 26 Hospitals, October 18, 2023-March 9, 2024Kevin C Ma, Diya Surie, Adam S Lauring, et al.
Open Forum Infectious Diseases|January 25, 2023
Absolute and Relative Vaccine Effectiveness of Primary and Booster Series of COVID-19 Vaccines (mRNA and Adenovirus Vector) Against COVID-19 Hospitalizations in the United States, December 2021-April 2022Nathaniel M Lewis, Nancy Murray, Katherine Adams, et al.
Pageof 42